6 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
Anticoagulant specific ... #anticoagulation ... clotting #INR #heparin ... #LMWH #NOAC #warfarin ... #Xarelto #apixaban
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Anticoagulants Common ... Reversal Agents - Warfarin ... /LMWH → Protamine ... (Praxbind) - Apixaban ... #doac #noac #pharmacology
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
(LMWH) - Enoxaparin ... - Warfarin - ... Xa inhibitors - Apixaban ... , rivaroxaban - ... #anticoagulation
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
- Pathophysiology ... (e.g. warfarin) ... #Heparins #LMWH ... #UFH #DOAC #Dabigatran ... #Apixaban #Rivaroxaban
Effect of Anticoagulants on Coagulation Tests
PT / INR, aPTT, Anti-Xa Activity, Activated Clotting Time, Thrombin Time,
on Coagulation ... Clotting Time Warfarin ... UFH LMWH Fondaparinux ... Rivaroxaban Apixaban ... #Testing #Diagnosis
The coagulation cascade is shown, separated into different phases with their endogenous and pharmacological inhibitors shown.
#Coagulation #Cascade ... #pathophysiology ... #anticoagulant ... #Warfarin #Dabigatran ... thrombin #inhibitor #Apixaban